Zobrazeno 1 - 10
of 264
pro vyhledávání: '"Aldo, Venuti"'
Autor:
Antonia Radaelli, Carlo Zanotto, Chiara Brambilla, Tommaso Adami, Francesca Paolini, Aldo Venuti, Adriana Manuka, Irsida Mehmeti, Carlo De Giuli Morghen
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-12 (2024)
Highlights Recombinant avipoxviruses as putative recombinant vaccines against MPXV. Different prime–boost regimens to improve immunization against orthopoxviruses. Mucosal and intramuscular immunization to enhance the humoral and neutralizing immun
Externí odkaz:
https://doaj.org/article/1c1531897baa4c83a54eca993ea56772
Autor:
Flaminia Campo, Oreste Iocca, Francesca Paolini, Valentina Manciocco, Silvia Moretto, Armando De Virgilio, Claudio Moretti, Antonello Vidiri, Aldo Venuti, Paolo Bossi, Giovanni Blandino, Raul Pellini
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-10 (2024)
Abstract Background Human papilloma virus (HPV) related cancers of the oropharynx are rapidly increasing in incidence and may soon represent the majority of all head and neck cancers. Improved monitoring and surveillance methods are thus an urgent ne
Externí odkaz:
https://doaj.org/article/c45d9903896b458481bb9a783a051808
Publikováno v:
Journal of Immunotherapy and Precision Oncology, Pp 79-85 (2021)
To date SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), a member of the Coronaviridae family, has infected more than 40 million people worldwide. A second wave of SARS-CoV-2 infection is aggressively surging. The clinical worsening of S
Externí odkaz:
https://doaj.org/article/759f466651eb4cc1b63a15d6502d6ad1
Autor:
Susanna Falcucci, Francesca Paolini, Anna Maria Mileo, Rosella Franconi, Silvia Massa, Antonio Rinaldi, Aldo Venuti
Publikováno v:
ACS Omega, Vol 6, Iss 13, Pp 8778-8783 (2021)
Externí odkaz:
https://doaj.org/article/313363cc05014bc3be155300f83be9ff
Autor:
Francesca Paolini, Carla Amici, Mariantonia Carosi, Claudia Bonomo, Paola Di Bonito, Aldo Venuti, Luisa Accardi
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 40, Iss 1, Pp 1-11 (2021)
Abstract Background The oncogenic activity of the high risk human papillomavirus type 16 (HPV16) is fully dependent on the E6 and E7 viral oncoproteins produced during viral infection. The oncoproteins interfere with cellular homeostasis by promoting
Externí odkaz:
https://doaj.org/article/0df7aadddb4048348870b9c52b122571
Autor:
Cathy Ventura, Ângelo Luís, Christiane P. Soares, Aldo Venuti, Francesca Paolini, Luísa Pereira, Ângela Sousa
Publikováno v:
Vaccines, Vol 10, Iss 9, p 1560 (2022)
Cervical cancer (CC) is a disease that affects many women worldwide, especially in low-income countries. The human papilloma virus (HPV) is the main causative agent of this disease, with the E6 and E7 oncoproteins being responsible for the developmen
Externí odkaz:
https://doaj.org/article/8401109d9c504dbc98b1f85c24ab3b38
Publikováno v:
Vaccines, Vol 10, Iss 5, p 648 (2022)
We live on a planet marked by remarkable health disparities [...]
Externí odkaz:
https://doaj.org/article/7fce3991ee4849098a56090caf5ce66e
Autor:
Francesca Paolini, Marco Zaccarini, Arianna Francesconi, Luciano Mariani, Luca Muscardin, Pietro Donati, Aldo Venuti
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
E7 protein from cutaneous as well as mucosal HPV types can alter NF-κB activity. Conflicting literature data show a HPV-induced up- or down-regulation of the NF-κB pathway in different cell lines. In a previous study we detected the expression of E
Externí odkaz:
https://doaj.org/article/3483d72a65e247e5843f21a249a18c2a
Autor:
Marconi Rego Barros, Cristiane Moutinho Lagos de Melo, Maria Luiza Carneiro Moura Gonçalves Rego Barros, Rita de Cássia Pereira de Lima, Antonio Carlos de Freitas, Aldo Venuti
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 37, Iss 1, Pp 1-18 (2018)
Abstract The immune system is composed of immune as well as non-immune cells. As this system is a well-established component of human papillomavirus- (HPV)-related carcinogenesis, high risk human papillomavirus (hrHPV) prevents its routes and mechani
Externí odkaz:
https://doaj.org/article/ce067a100459451c9f8f5b62b17ccb72
Autor:
Flaminia Campo, Aldo Venuti, Fulvia Pimpinelli, Elva Abril, Giovanni Blandino, Laura Conti, Armando De Virgilio, Federico De Marco, Vincenzo Di Noia, Enea Gino Di Domenico, Simona Di Martino, Fabrizio Ensoli, Diana Giannarelli, Chiara Mandoj, Francesco Mazzola, Silvia Moretto, Gerardo Petruzzi, Fabrizio Petrone, Barbara Pichi, Martina Pontone, Antonello Vidiri, Branka Vujovic, Giulia Piaggio, Eleonora Sperandio, Valentina Rosati, Francesco Cognetti, Aldo Morrone, Gennaro Ciliberto, Raul Pellini
Publikováno v:
Vaccines, Vol 9, Iss 10, p 1125 (2021)
Background: We present immunogenicity data 6 months after the first dose of BNT162b2 in correlation with age, gender, BMI, comorbidities and previous SARS-CoV-2 infection. Methods: An immunogenicity evaluation was carried out among health care worker
Externí odkaz:
https://doaj.org/article/36f99144cc484fcbaa1b52a1229d2fd0